Suppr超能文献

一项来自国家癌症数据库的垂体癌人群水平分析。

A Population-Level Analysis of Pituitary Carcinoma from the National Cancer Database.

作者信息

Carey Ryan M, Kuan Edward C, Workman Alan D, Patel Neil N, Kohanski Michael A, Tong Charles C L, Chen Jinbo, Palmer James N, Adappa Nithin D, Brant Jason A

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States.

Department of Biostatistics and Epidemiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States.

出版信息

J Neurol Surg B Skull Base. 2020 Apr;81(2):180-186. doi: 10.1055/s-0039-1683435. Epub 2019 Mar 15.

Abstract

Pituitary carcinoma is a rare entity with fewer than 200 total cases reported in the English literature. Analysis of the population-level data from the National Cancer Database (NCDB) affords the opportunity to study this poorly understood tumor type.  The NCDB was queried for site, histology, and metastasis codes corresponding to pituitary carcinoma. Statistical analyses were performed to determine factors associated with overall survival (OS).  A total of 92 patients with pituitary carcinoma met inclusion criteria. The 1 and 5 years of OS for all patients was 93.3% (95% confidence interval [CI]: 88.2-98.6%) and 80.0% (95% CI: 71.6-89.4%), respectively. Patients with invasive primary tumor behavior had 1 and 5 years of OS of 69.2% (95% CI: 48.2-99.5%) and 52.7% (95% CI: 31.2-89.2%), respectively. Multivariate analysis demonstrated that compared with benign primary behavior, invasive behavior had increased all-cause mortality (hazard ratio [HR], 1,296, 95% CI: 15.1- > 2,000). Surgery without adjuvant radiation or chemotherapy was the most common therapy (48.9%), followed by no treatment (40.2%). Compared with surgery alone, no treatment had worse OS (HR, 11.83, 95% CI: 1.41-99.56). Increasing age and female sex were both associated with increased mortality.  The most common treatment for pituitary carcinoma is surgery alone followed by no surgery. Surgery alone has significantly better OS compared with no treatment. The efficacy of radiation, chemotherapy, and neurohormonal treatments needs to be examined with prospective studies.

摘要

垂体癌是一种罕见的疾病,英文文献报道的病例总数不足200例。分析国家癌症数据库(NCDB)的人群水平数据为研究这种了解甚少的肿瘤类型提供了机会。

查询NCDB中与垂体癌对应的部位、组织学和转移编码。进行统计分析以确定与总生存期(OS)相关的因素。

共有92例垂体癌患者符合纳入标准。所有患者的1年和5年总生存率分别为93.3%(95%置信区间[CI]:88.2 - 98.6%)和80.0%(95%CI:71.6 - 89.4%)。具有侵袭性原发性肿瘤行为的患者1年和5年总生存率分别为69.2%(95%CI:48.2 - 99.5%)和52.7%(95%CI:31.2 - 89.2%)。多变量分析表明,与良性原发性行为相比,侵袭性行为增加了全因死亡率(风险比[HR],1.296,95%CI:15.1 - >2000)。未进行辅助放疗或化疗的手术是最常见的治疗方法(48.9%),其次是未治疗(40.2%)。与单纯手术相比,未治疗的总生存期更差(HR,11.83,95%CI:1.41 - 99.56)。年龄增加和女性性别均与死亡率增加相关。

垂体癌最常见的治疗方法是单纯手术,其次是不手术。与未治疗相比,单纯手术的总生存期明显更好。放疗、化疗和神经激素治疗的疗效需要通过前瞻性研究来检验。

相似文献

1
A Population-Level Analysis of Pituitary Carcinoma from the National Cancer Database.
J Neurol Surg B Skull Base. 2020 Apr;81(2):180-186. doi: 10.1055/s-0039-1683435. Epub 2019 Mar 15.
2
Adenocarcinoma of the Sinonasal Tract: A Review of the National Cancer Database.
J Neurol Surg B Skull Base. 2020 Dec;81(6):701-708. doi: 10.1055/s-0039-1696707. Epub 2019 Sep 12.
3
Patient, disease, and treatment factors associated with overall survival in esthesioneuroblastoma.
Int Forum Allergy Rhinol. 2017 Dec;7(12):1186-1194. doi: 10.1002/alr.22027. Epub 2017 Oct 17.
4
Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
Eur Urol Focus. 2018 Dec;4(6):900-906. doi: 10.1016/j.euf.2017.09.001. Epub 2017 Sep 14.
5
Characteristics and overall survival in pediatric versus adult pituitary adenoma: a National Cancer Database analysis.
Pituitary. 2021 Oct;24(5):714-723. doi: 10.1007/s11102-021-01146-3. Epub 2021 Apr 30.
6
9
Overall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands: Analysis of 2210 patients.
World J Clin Oncol. 2020 Dec 24;11(12):1029-1044. doi: 10.5306/wjco.v11.i12.1029.
10
Impact of Treatment Modalities upon Survival Outcomes in Skull Base and Clival Chordoma: An NCDB Analysis.
J Neurol Surg B Skull Base. 2022 Feb 17;84(1):60-68. doi: 10.1055/a-1733-9475. eCollection 2023 Feb.

引用本文的文献

1
Neuro-ophthalmological findings of pituitary metastasis: Case series from a single center and review of the literature.
Heliyon. 2024 Feb 7;10(4):e26027. doi: 10.1016/j.heliyon.2024.e26027. eCollection 2024 Feb 29.
2
Determinants of Patient Refusal of Postoperative Radiation Therapy in Sinonasal Squamous Cell Carcinoma.
J Neurol Surg B Skull Base. 2022 Jun 6;84(3):232-239. doi: 10.1055/a-1780-4157. eCollection 2023 Jun.
3
Natural history of pituitary carcinoma with metastasis to the cervical spine: illustrative case.
J Neurosurg Case Lessons. 2023 Jan 16;5(3). doi: 10.3171/CASE22363.

本文引用的文献

1
Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review.
Pituitary. 2018 Jun;21(3):290-301. doi: 10.1007/s11102-018-0872-8.
2
Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).
Pituitary. 2018 Apr;21(2):217-229. doi: 10.1007/s11102-017-0857-z.
3
4
Successful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resection.
J Clin Neurosci. 2017 Jul;41:75-77. doi: 10.1016/j.jocn.2017.02.052. Epub 2017 Mar 11.
7
Invasive adenoma and pituitary carcinoma: a SEER database analysis.
Neurosurg Rev. 2014 Apr;37(2):279-85; discussion 285-6. doi: 10.1007/s10143-014-0525-y. Epub 2014 Feb 14.
8
Cancer recurrence: an important but missing variable in national cancer registries.
Ann Surg Oncol. 2014 May;21(5):1520-9. doi: 10.1245/s10434-014-3516-x. Epub 2014 Feb 7.
9
Clinical review: Pituitary carcinoma: difficult diagnosis and treatment.
J Clin Endocrinol Metab. 2011 Dec;96(12):3649-60. doi: 10.1210/jc.2011-2031. Epub 2011 Sep 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验